Aims: High fat diet consumes and thyroid hormones (THs) disorders may affect nutrients metabolism, but their impact on the absorptive epithelium, the first place of nutrients access, remains unknown. Our aim was to evaluate the intestinal morphology and nutrients transporters content in mice fed standard (LFD) or high fat (HFD) diets in hypo or hyperthyroidism-induced condition. Material and methods: C57BL/6 male mice fed LFD or HFD diets for 12 weeks, followed by saline, PTU (antithyroid drug) or T3 treatment up to 30 days. The mice were euthanized and proximal intestine was removed to study GLUT2, GLUT5, PEPT1, FAT-CD36, FATP4, NPC1L1 and NHE3 distribution by Western blotting. Since PPAR-a is activated by fatty acids, which is abundant in the HFD, we also evaluated whether PPAR-a affects nutrients transporters. Thus, mice were treated with fenofibrate, a PPAR-a agonist. Key findings: HFD decreased GLUT2, PEPT1, FAT-CD6 and NPC1L1, but increased NHE3, while GLUT5 and FATP4 remained unaltered. THs did not alter distribution of nutrients transporters neither in LFD nor in HFD groups, but they increased villi length and depth crypt in LFD and HFD, respectively. Fenofibrate did not affect content of nutrients transporters, excluding PPAR-a involvement on the HFD-induced changes. Significance: We assume that chronic HFD consumption reduced most of the nutrients transporters content in the small intestine of mice, which might limit the entrance of nutrients and gain weight. Since NHE3 promotes sodium absorption, and it was increased in HFD group, this finding could contribute to explain the hypertension observed in obesity.
Introduction
The nutrients absorption through the mucosa of the gastrointestinal (GI) tract is essentially controlled by the nervous and endocrine systems. The small intestine, especially its proximal segment, is where most of the products of the macronutrients hydrolysis are absorbed by specific transporters placed at the brush border membrane of enterocytes [1] .
Monosaccharides transport, such as glucose, galactose and fructose are mediated by sodium-coupled glucose transporter −1 (SGLT1) and glucose transporter −5 (GLUT5), respectively, which are located at the apical membrane of enterocytes, whereas the efflux of these monosaccharides occursthrough the GLUT2 placedat the basolateral membrane [2] . However, some studies point to the presence of GLUT2 in the apical membrane as well, mainly in the postprandial period, which may contribute to monosaccharides absorption [3] .
The absorption of peptides occurs mainly by cotransport with hydrogen, being mediated by the peptide transporter −1 (PEPT1) [4] . This process depends on a proton gradient generated by the activity of sodium-hydrogen exchangers (NHE), mainly the NHE3 isoform at enterocyte apical surface [5] . The cholesterol transport is mediated by Niemann-Pick C1-like 1 (NPC1L1) and the long chain fatty acids (LCFA) absorption is promoted by specific proteins, such as fatty acid translocase (FAT-CD36) and fatty acid transport protein −4 (FATP4), but the molecular mechanism of fatty acids absorption is not completely understood yet [6, 7] .
In the lumen of GI tract, the nutrients control processes responsible for their own digestion by triggering neural and endocrine responses, but there are growing evidences supporting a putative role of these nutrients on their own uptake into enterocytes, as well [8] .
In fact, fat consumption is associated with increased expression of the fatty acid transporter FAT-CD36 in the proximal segment of the rat small intestine by an unknown mechanism [9] . Moreover increased fat acids consumption can activate transcriptional factors, such as the peroxisome proliferator-activated receptor (PPAR) [10] ,and PPAR alpha (PPAR-a) agonists were shown to regulate the mRNAs content of nutrients transporters, such as those for carbohydrate and cholesterol [11] . Taking into account that PPAR-a is the major isoform expressed in the intestine; the fatty acids are PPAR natural ligands, and fat digestion increases fatty acids in the lumen of GI tract, it is possible that PPAR-a might be activated by lipids from dietand regulate nutrients transporters content.
Likewise, hormones that play a role on the control of energy metabolism might also modulate the absorption of nutrients by acting on the intestine. In this sense, thyroid hormones (THs) could be putative candidates, considering that they have important effects on carbohydrate, lipid and protein metabolism, and that the absorptive epithelium is the first access to nutrients into the organism. However, data on this issue are scarce and poorly explored.
It is has been pointed out that T3 increases the uptake of D-glucose in the chicken jejunum [12, 13] and T4 decreases thePEPT1 mRNA and protein content in the enterocyte, as well as the concentration of its substrate, thedipeptide glycylsarcosine, in the portal bloodstream [14] , while the expression of NPC1L1 in the intestine was reported to be unaltered by T4 treatment [15] . Nevertheless, the regulation of FAT-CD36 and FATP4 by THs is still unexplored in the intestine.
Taking into account the few available experimental data about the mechanisms involved in the modulation of the nutrient transporters expression by high fat diet and THs, and that obesity and THs disorders are the most prevalent in the population, the present study aimed at investigating the effect of high fat consumption, associated or not with hypo and hyperthyroidism, on the regulation of the enterocytes nutrients transporters content.
Methods

Animals
Male mice (C57BL/6 strain) were obtained from the Animal Facility at Faculty of Medicine of the University of São Paulo and the protocol was approved by the Ethical Committee on Animal Use (protocol number 106/2014). Mice were maintained under controlled temperature ( ± 23°C) and in a 12:12 h light-dark cycle; they were fed with standard diet (LFD) or high fat diet (HFD) from two to five months of age, and water was offered ad libitum. Total calories of LFD were provided by 70% of carbohydrates, 20% of proteins and 10% of fat, while of HFD were provided by 20% of carbohydrates, 20% of proteins and 60% of fat, exactly according to Belchior and colleagues [16] and produced by PragSoluções Biociências Company. Three months after LFD or HFD feeding the mice were once daily treated with subcutaneous injections of either propylthiouracil (PTU: 12.5 mg/Kg, from Sigma-Aldrich) or triiodo-L-thyronine (T3: 0.25 μg/g, from Sigma-Aldrich) for 30 days more for hypo or hyperthyroidism induction, respectively. The time and dosage of PTU and T3 used were based in previous studies [17, 18] . Control mice fed LFD or HFD received saline as vehicle.Moreover, we also evaluate the impact of fenofibrate, a PPAR-alpha agonist on the small intestine of mice.For that, mice fed with LFD were once daily treated with fenofibrate from Sigma-Aldrich (100 mg/Kg) or sorbitol (vehicle) by gavage, for 12 days [19] . All mice were euthanized at six-month of age by decapitation, under isoflurane inhalation anesthesia. The perigonadal fat, tibia bone and heart were removed to be used in the analysis of the effectiveness of the interventions and pituitaries were collected to evaluate the Tshb gene expression by RT-qPCR (Table 1) .
Oral glucose tolerance test
The mice were submitted to the glucose tolerance test (GTT) after they have completed five months of age. The animals were fasted for 6 h for OGTT. Before administration of the glucose bolus by gavage (2 g/kg) the blood glucose levels was checked. After gavage, we collected blood from the caudal vein to determine glycaemia in the following times: 30, 60 and 90 min. The blood glucose levels were determined by a glucose meter (Roche, ACCU-CHEK Active). These protocols were adapted from Hwang and colleagues [20] .
Intestinal epithelium isolation
The epithelial cell isolation technique was adapted from Santos and colleagues [21] . Briefly, the small intestine was removed, the initial 3 cm from the pylorus region were discarded and the following 2 cm was collected for histological analysis. For protein analysis by Western blotting, the initial 5 cm of the small intestine were discarded and the following 10 cm was collected, which corresponds to the proximal portion of jejunum. The intestine was then opened to expose the mucosa, cut into ± 0.5 cm pieces, washed with cold saline to remove the luminal contents and subjected to one bath in washing solution (3.2 mM dithiothreitol and 3 mM sodium azide, both dissolved in saline) for 5 min at room temperature (RT), followed by one bath in phosphatebuffered saline (PBS, pH 7.4) for 20 min at 4°C. The intestine pieces were transferred to Erlenmeyer flasks and subjected to constant stirring (200 rpm/60 min/37°C: in Orbital shaker, Model 420, ThermoFisher Scientific, USA) in a solution containing PBS, 0.5 mM dithiothreitol and 1.5 mM EDTA without calcium and magnesium. At the end, the solution was filtered, the intestine pieces were removed and the supernatant was centrifuged at 2000 rpm (centrifuge 5804 R from Eppendorf, Germany), for 10 min at 4°C. The pellet, which corresponds to intestinal epithelium, was then dissolved by mechanical stirring in lysis buffer [22] , and the homogenate was stored at −80°C until the day of processing for Western blotting technique. The efficiency of the intestinal epithelium isolation was confirmed by hematoxylin-eosin staining, as shown by the presence of connected columnar cells indicated by arrow (Supplemental Fig. 1 ).
Intestinal morphological analyses
Two centimeter of the proximal small intestine were removed, opened, stretched on paper card, washed in cold-saline, and immediately fixed in 10% formaldehyde for 24 h. The organ was embedded in paraffin (Sigma-Aldrich), sliced into 5 μm sections, deparaffinized and submitted to the hematoxilin-eosin staining. The length of the first 10 villi of each mouse was measured from the base to the top of the villi, and the measure of crypts depth comprised the extension between the crypt-villus junction and the base of the crypt (34-46 crypts/ mouse). All these measurements were made on photomicrographs acquired at X 20 (Image-Pro-Plus 5.1 software) under light microscope (Olympus BX40).
Western blotting
After thawing, the homogenate was centrifuged at 13000 rpm (centrifuge 5804 R from Eppendorf, Germany) for 20 min at 4°C, the supernatant was removed and the total protein content was determine by Bradford's method [23] . Samples containing 90 μg of total protein were heated, electrophoresed in 8% SDS-PAGE, and transferred to the nitrocellulose membrane (Bio-Rad Laboratories, Inc., USA). Molecular weight marker proteins were included in the first lane of each gel (ACTGene, Inc., USA). After transfer, the membranes were stained with Ponceau S, scanned and blocked with 5% skimmed milk dissolved in PBS plus 0.1% Tween 20 (PBST) under constant stirring and at RT for at least 1 h. The membranes were incubated with specific primary antibodies addressed to the proteins of interest at 4°C overnight. Primary antibodies were dissolved in 2.5% skimmed milk in PBST (1:1000). All antibodies were obtained from Santa Cruz Biotechnology, Inc. (USA), except the GLUT5 antibody, which was purchased from GeneTex, Inc. (USA).
The membranes were then washed four times with PBST, incubated with appropriated peroxidase-conjugated antibody (Jackson Immunoresearch laboratories, Inc., USA) for 75 min at RT, washed four times with PBST and submitted to Enhanced Chemiluminescent (ECL) detection. Bands were captured using a photodocumentation system (Amershan Imager 600, GE Healthcare Company, UK), and quantified using the Image J software program (National Institutes of Health, USA). The membranes were stained with Ponceau S and used to check equal loading of the gels and normalize the blots for protein levels [24] , since GAPDH was down-regulated in the small intestine of mice fed HFD (data not shown). For the experiments with fenofibrate the GAPDH was used as endogenous control to normalize the blots for protein levels. The Ponceau S images used for normalization are shown in the Supplementary Fig. 2 .
Quantitative real-time PCR for Tshb mRNA
Total RNA was extracted from the mice pituitary gland using Trizol according to the manufacturer's instructions. The samples were treated with Turbo DNA-free™ (Ambion, USA), and 1 μg was reverse transcribed with M-MLV Reverse Transcriptase (50,000 U; Promega®, USA). The reverse transcription reaction was subjected to RT-qPCR using Platinum® Syber® qPCR Supermix-UDG in a Corbett Research system (Corbett Life Sciences, Australia). Gapdh (forward: GGGCTGCCCAGAA CATCAT; reverse: CCGTTCAGCTCTGGGATGAC; 76 bp) was used as internal standard for normalization of gene expression levels of Tshb (forward: GGCAAACTGTTTCTTCCCAA; reverse: GTTGGTTTTGACAGC CTCGT; 198 bp). The efficiency values and slope for Gapdh (0,96 and −3,6373, respectively) and Tshb (1,38 and −2653, respectively) were close to the optimal values required for ddCT analysis [25, 26] . The Gapdh and Tshb expression was tested in all groups using the ΔCt ("cycle threshold") analysis. The relative expression levels of Tshb transcripts were normalized against Gapdh, the internal control gene whose expression did not significantly differ in the experimental conditions/groups.
Statistical analysis
The data were expressed as mean ± standard deviation (SD) and submitted to the appropriated statistical test. Parametric test was used for data with normal distribution of probability and homogeneity of variances or, in the absence of them, non-parametric test was applied. We have chosen two-way ANOVA with repeated measures for body weight and blood glucose, followed by Bonferroni's multiple comparisons test, when appropriated. We have chosen two-way ANOVA for GLUT2, GLUT5, PEPT1, NHE3, FAT-CD36, FATP4 and NPC1L1 (Fig. 1 , The body weight, perigonadal fat weight, heart weight and Tshb subunit gene expression were analyzed. The body weight (BW) was measured on the day of euthanasia and its values are expressed in grams. The perigonadal fat were removed, weighed and normalized by total body weight. The heart were removed, weight and normalized by tibia length. The data for body weight, fat and heart correspond to three independent experiments, with a total of 12 to 15 animals per group. The pituitary Tshb mRNA content was evaluated by real-time PCR and its values normalized by Gapdh mRNA (internal control). The Tshb mRNA data correspond to two independent experiments, with a total of 8 to 10 animals per group. The data were submitted to statistical analysis: two-way ANOVA, followed by Tukey post-test and are expressed as mean ± standard deviation ( 3, 4 and 5) and one-way ANOVA for villus length and crypts depth measurements (Fig. 2) , followed by Tukey's multiple comparisons test, when appropriated. For the experiments with Fenofibrate, Student's ttest was chosen (Fig. 6) . The statistical details are mentioned in figures legends and the differences were considered significant at p < 0.05. Statistical analyzes were carried out in the GraphPad Prism 7.04.
Results
Morphofunctional parameters and assessment of treatment effectiveness for hypo and hyperthyroidism induction
The body weight of the animals on the 6th and 12th weeks of HFD and LFD feeding and the glucose tolerance test (GTT) performed at the end of the 12th week of the treatments are shown in Fig. 1 . A gradual body weight increase over the 12th weeks of HFD feeding (Fig. 1A) was observed, as well as a clear glucose intolerance (Fig. 1B) , as expected. The increased pituitary Tshb mRNA expression in PTU-treated mice confirmed hypothyroidism, while the cardiac hypertrophy and the decreased perigonadal fat and Tshb mRNA expression confirmed hyperthyroidism in T3-treated mice. The obese mice that were treated with T3 also presented reduction of the body weight. These data are shown in Table 1 . 
Analysis of the villi length and crypts depth of small intestine of LFD and HFD-fed mice and the involvement of thyroid hormone
The HFD mice treated with saline did not show any alteration in the villi length compared to saline-treated LFD mice ( Fig. 2A and C ; black bars). LFD mice treated with PTU or T3 showed increased villi length compared to the saline-treated mice ( Fig. 2A and B) . The PTU and T3 treatment did not affect the villi length in HFD mice (Fig. 2C and D) . Regarding the crypt depth any difference was observed between salinetreated HFD and LFD mice (Fig. 2E and G, black bars) . PTU and T3 treatment did not change the crypt depth of LFD mice, as well, when compared to saline-treated LFD mice (Fig. 2E and F) . However, HFD T3-treated mice showed an increase in the crypt depth compared to the saline and PTU-treated HFD mice (Fig. 2G and H) . 
Impact of high fat consumption on nutrients transporters content and the involvement of thyroid hormones
The nutrients transporters were evaluated in the small intestine as follows: GLUT2 and GLUT5 for carbohydrates, PEPT1 for peptides uptake, and FATP4, FAT-CD36 and NPC1L1 for lipids absorption. HFD consumption altered the content of almost all them, independent of treatment. HFD intake decreased GLUT2 content, while GLUT5 content remained unaltered (Fig. 3) . HFD consumption also decreased the PEPT1 content, while increased NHE3 content (Fig. 4) . Regarding lipids transporters, HFD did not change the FATP4, but decreased FAT-CD36 and NPC1L1 content (Fig. 5) . The PTU and T3 treatment did not affect the nutrients transporters content, except for FAT-CD36 which was increased in the small intestine of LFD and HFD-T3 treated mice (Fig. 5B) .
Fenofibrate treatment did not affect the nutrients transporters content in the small intestine of LFD mice
The fenofibrate treatment did not alter the content of any of the nutrients transporters, such as, GLUT2, GLUT5, PEPT1, FATP4, FAT-CD36, NPC1L1 and NHE3 compared to mice treated with vehicle. On the other hand, fenofibrate administration induced an increasing of the L-FABP content, as shown. The data are shown in Fig. 6 .
Discussion
The present study showed that the HFD consumption affects the content of nutrients transporters in the absorptive epithelium of the small intestine of mice. These changes are extremely relevant due to the scarcity of studies that explore the impact of nutrients in the regulation of the basic processes of GI tract, such as, absorption of lipids, proteins and carbohydrates. It is worth to mention that nutrients transporters located at the apical membrane of the enterocytes are continuously exposed to the hydrolysis products of the macronutrients, which are already known to regulate their own digestion by direct mechanism or by stimulation of the release of intestinal hormones [8, 27] . However, as far as we know, there has been no systematic study evaluating the effect of HFD on the expression of the nutrients transporters.
Indeed, the high consumption of fat decreased the NPC1L1 content, as previously described [28, 29] which may decrease the cholesterol absorption, since NPC1L1 exerts important role in this process. This effect point out to a mechanism elicited by the HFD at the intestinal barrieron NPC1L1 expression which might help the control of the cholesterol levels in the bloodstream, which are known to bedirectly associated with high incidence of cardiovascular diseases [30] .
Regarding the LCFA transporters in the mice's absorptive epithelium, the content of one of them, the FAT-CD36 was decreased in response to HFD consumption. This finding seems to be in disagreement with those reported in earlier studies [9, 31] that pointed to increase of the FAT-CD36 mRNA in the small intestine of HFD animals. However, these researchers found out an increase of FAT-CD36 mRNA expression, and we evaluated the FAT-CD36 protein content and discrepancies between mRNA expression and protein content is a common finding in many conditions, as previously reported [32, 33] .
HFD also decreased the PEPT1 protein content in the small intestine, which is in agreement with a study that showed a reduction of PEPT1 mRNA and protein content as well as in its activity in the intestine of mice fed HFD [34] . As PEPT1 transports dipeptides and tripeptides, the main products generated from protein digestion, we may infer that peptides absorption is impaired; indicating that, in parallel to the high influx of fatty acids, the consumption of HFD might reduce the amino acids supply for tissues. Nevertheless, the transport of these peptides depends on the activity of NHE3 located at the apical membrane of enterocytes [35, 36] , despite of the PEPT1 reduction, we showed that HFD consumption increased the NHE3 content in the small intestine, which might function as a compensatory mechanism to counteract the reduction PEPT1 content. As far as we know, this is the first evidence that this protein may be regulated by fat in the intestine. In fact, there are reports about NHE3 modulation by fat in the kidney, but they are scarce and contradictory [37, 38] . NHE3 is also important for sodium absorption from the GI tract, as shown by the diarrhea that occurs in its absence secondary to the sodium impairment absorption [35] . Thus the increased NHE3 content induced by HFD may favor the increase of sodium absorption. Thus, we are attempted to infer that increased NHE3 content induced by HFD might contribute for the establishment of the hypertension, which is a common finding in obesity [39] .
HFD mice also showed a decrease of the GLUT2 content, which are important carbohydrate transporter, suggesting an impairment of the monosaccharides absorption in this condition since GLUT2 transports glucose, galactose and fructose. It is worth to mention that GLUT2, usually located at the basolateral membrane, may be found in the apical membrane mainly in the postprandial period, contributing to the carbohydrate absorption [3] . Therefore, the reduction of that carbohydrate transporter may limit the amount of carbohydrate absorbed from the diet.
Altogether, these results point to an important role of the HFD in modulating nutrients transporters. It is especially noticeable the reduction of carbohydrates and peptides absorption induced by this diet, since they are important metabolites that signal the need for energy and also the reduction of food intake.
Regarding the involvement of thyroid hormones (THs) in the effects of LFD or HFD in intestine of mice, T3 was shown to induce an increase of the crypts depth in HFD mice, while in LFD mice T3 as well as PTU increased the villi length.Despite the larger villus height is an indicative of increased number of enterocytes, this seems not to be related to the nutrients transporters content, since GLUT2, GLUT5, PEPT1, NPC1L1 and FATP4 remained unaltered after chronic PTU or T3 treatments. The only modification induced by the chronic T3 treatment was the increase of the FAT-CD36 content in the intestine. A similar finding was reported in the red section of the gastrocnemius muscle of T3-treated rats [40] . This T3 effect suggests that T3 controls of FAT-CD36 content independently of the diet, which is in line with the participation of T3 in uptake and oxidation of fatty acids, which is particularly important, considering the increased energy demand that occurs in the . # GLUT2 (60 kDa) and NHE3 (85 kDa) were normalized by the same GAPDH (37 kDa) since they were electrophoresed in the same SDS-PAGE. * GLUT5 (55 kDa) and NPC1L1 (145 kDa) were normalized by the same GAPDH as well.
hyperthyroidism states.
Despite we have not identified any modulation of the nutrients transporters by TH, the GI tract expresses THs receptors [41] and there are evidences that THs activate the intestinal motility [42] and regulate the Oddi-sphincter contraction [43] , which identifies the GI tract a target for THs actions.
Even though dietary fat was shown to modulate GLUT2, PEPT1, NHE3, NPC1L1 and FAT-CD36 protein content in the intestine, more studies have to be performed to identify the mechanisms involved in such actions. It is known that fatty acids, mainly polyunsaturated fatty acids, may activatethe transcription factor peroxisome proliferator-activated receptor alpha (PPAR-a), the most expressed PPAR isoform in the small intestine [11] . Fenofibrate is a PPAR-a agonist, and we perform experiments in order to evaluate whether PPAR-a could be involved in the alterations induced by HFD consumption, since fatty acids from diet could activate it. However, no effect of fenofibrate was detected on the nutrients transporters' content, excluding a possible role of the PPAR in the alterations observed in HFD mice. To confirm the efficiency of fenofibrate treatment, we evaluated the expression of liver-fatty acid binding protein (L-FABP) in the small intestine, since its gene is up-regulated by the PPAR-a [44] . As expected, fenofibrate administration increased the L-FABP content, indicating that fenofibrate treatment was efficient.
Conclusion
In summary, this study pointed to a role of the dietary fat on the content of carbohydrates, lipids and proteins transporters, indicating that the flux of the metabolites through intestinal epithelium could be modified by HFD. This may implicate in alterations in the metabolic signaling exerted by these metabolites on the control of hormones release and food intake, as suggested by the decreased expression of carbohydrates and peptides transporters. The enhanced NHE3 content induced by HFD indicates that the sodium transport could be increased, which might contribute to the installation of hypertension in obese mice.Even though PPAR has been pointed out as a regulator of nutrients transporters gene expression, this study did not show any participation of it in this process. Thyroid hormones seem not to participate in these processes as well.
Supplementary data to this article can be found online at https:// doi.org/10.1016/j.lfs.2018.03.053.
